inoa huahana:Noopept,GVS-111

inoa ʻē aʻe: N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester

CAS NO：157115-85-0

Nā kikoʻī: 99.5%

kala kala:Keʻokeʻopauda me ke ʻala a me ka ʻono

Kūlana GMO: ʻAʻole GMO

Hoʻopili: ma 25kgs fiber drums

Ka mālama ʻana: E mālama i ka pahu i wehe ʻole ʻia ma kahi maloʻo a maloʻo, e haʻalele i ka mālamalama ikaika

Ola Ola: 24 mahina mai ka lā i hana ʻia

NoopeptʻO GVS-111 kahi lāʻau cognitive a me ka neuroprotective e hoʻomaʻamaʻa i ke kaulike ma waena o nā ʻōnaehana nerve a me nā antioxidant.

1-(2-Phenylacetyl)-L-prolylglycine Ethyl Ester i ʻike ʻia ʻo Noopept, he dipeptide synthetic, i hōʻike ʻia i ka hopena nootropic a me ka cognitive maikaʻi i nā holoholona. Ua hōʻike nā haʻawina kanaka i nā hopena hoʻohiki, me ka hiki ke hoʻohana i ka mālama ʻana i ka maʻi o Alzheimer.

ʻO Noopept kahi pūhui peptide synthetic i kūkulu ʻia ma Rūsia i nā makahiki 1990 e hoʻomaikaʻi i ka hana cognitive. Hoʻokaʻawale ʻia ʻo ia he nootropic, ʻo ia ka mea e hoʻonui ai i ka hana o ka lolo a me nā mana cognitive, me ka hoʻomanaʻo, ka noʻonoʻo, a me ke aʻo ʻana. Hoʻonui ka Noopept i ka hoʻomanaʻo a me ke aʻo ʻana ma o ka hoʻolaha ʻana i ka hoʻokuʻu ʻana o kekahi mau neurotransmitters e hoʻoulu i ka hana neuron. Kōkua kēia i ka hana ʻana i nā hoʻomanaʻo hou a mālama pono i ka ʻike. Hoʻohui ʻia, manaʻo ʻia ʻo Noopept he hopena maikaʻi i ka manaʻo holoʻokoʻa. Ma ka hoʻolaha ʻana i ka noʻonoʻo maʻalahi, hoʻomaikaʻi ia i ka huahana a me ka maikaʻi i nā hana like ʻole, ke aʻo ʻana a i ʻole ka hana ʻana i nā papahana paʻakikī. Ke hōʻike nei nā noiʻi pili e loaʻa paha iā Noopept nā waiwai neuroprotective e kū'ē i ke kaumaha oxidative a me ka neurotoxicity. Manaʻo ʻia kēia mau waiwai e pale i ka emi ʻana o ka cognitive pili i ka makahiki a hoʻemi i ka hopena o nā maʻi neurodegenerative.

Hana:

ʻO 1-(2-Phenylacetyl) -L-prolylglycine Ethyl Ester, he dipeptide synthetic, i hōʻike ʻia i ka hopena nootropic a me ka cognitive maikaʻi i nā holoholona. Ua hōʻike nā haʻawina kanaka i nā hopena hoʻohiki, me ka hiki ke hoʻohana i ka mālama ʻana i ka maʻi o Alzheimer.
1. Hoʻonui i ka hoʻohui
2. Hoʻomaikaʻi i ke ʻano
3.Helps kaua i ka luhi
4.Prevents oxidation i loko o ka lolo
5.Treats ka waiʻona pili i ka lolo
6.Prevents caff eine withdrawal symptoms

Noi:

ʻO Noopept ka inoa inoa no ka N-phenylacetyl-L-prolylglycine ethyl ester, he synthetic nootropic mole. Noopept ka hopena like me ka piracetam, no ka mea, hāʻawi ia i kahi hoʻoikaika cognitive haʻahaʻa ma hope o ka supplementation. Hāʻawi ʻo Noopept i kahi hopena psychostimulatory maʻalahi.
ʻO Noopept, kahi mea hoʻoikaika naʻau ikaika, ua hoʻomohala ʻia ma Rūsia i ka hoʻomaka ʻana o 2000s no ka mālama ʻana i ka hōʻino ʻana i ka lolo. ʻO kahi mea hoʻohui noʻonoʻo, ʻo Noopept kahi mea ikaika e hiki ai ke hele i ka pale lolo koko. Hana nui ia ma ka hoʻopaʻa ʻana i nā mea hoʻokipa glutamate a me ka hoʻohana ʻana i nā hopena neuroprotective ikaika ma ka lolo. ʻO kona bio-availability kiʻekiʻe ʻo ia hoʻi ka wikiwiki o ka hana a hiki ke loaʻa i kahi hopena kumulative. ʻOiai ʻo ia ka mea i ʻike nui ʻia ma ke ʻano he kīʻaha lolo, hoʻonui pū ʻo Noopept i ka coordination a hoʻomaikaʻi i ke ʻano. Hiki iā ia ke kōkua i ke kaua ʻana i ka luhi a pale i ka wehe ʻana o ka cafe ine me nā hopena ʻaoʻao ʻike ʻole. He mea kōkua maikaʻi loa ia no ke aʻo ʻana, no ka mea, ʻaʻole ia e hoʻoulu i ka insomnia.
Ke hōʻike nei kekahi mau noiʻi e hiki ke kōkua kēia kumulāʻau i ka pale ʻana i ka pōʻino oxidization i ka lolo. Hoʻohana pū ia no ka mālama ʻana i ka pōʻino o ka lolo e pili ana i ka waiʻona (ʻo ia ke kumu kumu no kona hoʻomohala ʻana).